Overview
In this study the investigators aim to study the effect of supplementation of CoQ10 in decreasing the incidence of contrast induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.
Description
Patients who fulfilled the inclusion criteria and agreed to participate in the study will be randomly divided into 2 groups using their computer generated random numbers that group a will receive the coenzyme Q10 in addition to the standard preventive measures and group b will receive only the standard preventive measures without the coenzyme Q10.
Eligibility
Inclusion Criteria:
- Patients who are 18 years or older.
- ST-elevation myocardial infarction (STEMI).
- Non ST-elevation myocardial infarction( NSTEMI).
- Unstable Angina (UA)
Exclusion Criteria:
- Renal transplant patients.
- Preoperative bleeding .
- Intraoperative bleeding or hypotension.
- Patients taking any nephrotoxic medications